Phase II Study of the GI-4000 KRAS Vaccine After Curative...

Clinical Lung Cancer 2014 / 11 Vol. 15; Iss. 6

Phase II Study of the GI-4000 KRAS Vaccine After Curative Therapy in Patients With Stage I-III Lung Adenocarcinoma Harboring a KRAS G12C, G12D, or G12V Mutation

Chaft, Jamie E., Litvak, Anya, Arcila, Maria E., Patel, Payal, D'Angelo, Sandra P., Krug, Lee M., Rusch, Valerie, Mattson, Alicia, Coeshott, Claire, Park, Bernard, Apelian, David M., Kris, Mark G., Az
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Language:
english
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2014.06.002
Date:
November, 2014
File:
PDF, 611 KB
english, 2014
Conversion to is in progress
Conversion to is failed